JMP Securities Issues Positive Forecast for Exelixis (NASDAQ:EXEL) Stock Price

Exelixis (NASDAQ:EXEL – Free Report) had its price objective raised by JMP Securities from $47.00 to $50.00 in a report released on Monday morning,Benzinga reports. They currently have a market outperform rating on the biotechnology company’s stock. Other equities analysts have also recently issued research reports about the company. Royal Bank Of Canada reissued an […]

Leave a Reply

Your email address will not be published.

Previous post R8 Capital Investments (LON:MODE) Shares Down 0.3% – Should You Sell?
Next post Purple Biotech (NASDAQ:PPBT) Stock Price Up 0.9% – Here’s Why